A detailed history of Cgc Financial Services, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Cgc Financial Services, LLC holds 65 shares of NVO stock, worth $7,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
65
Previous 65 -0.0%
Holding current value
$7,158
Previous $9.28 Million 16.58%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$102.11 - $135.92 $510 - $679
5 Added 8.33%
65 $8.35 Million
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $5,266 - $6,327
60 New
60 $6.21 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $249B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Cgc Financial Services, LLC Portfolio

Follow Cgc Financial Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cgc Financial Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cgc Financial Services, LLC with notifications on news.